SDI ASX Week ended 10 Jul 2026

Weekly Investor Report

Name: SDI weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

SDI Limited · Healthcare · Medical Instruments & Supplies

Open interactive chart View report data

Latest close 1.40 AUD

0.0% latest week

Weekly setup

Constructive, but selective

The weekly trend is active. Price is 20.2% above the Trend Line and sits at 99.6% of its 52-week range. The latest completed week returned 0.0%, after a 3.1% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers. The latest news-sentiment score is 50/100. Near-term considerations: price is close to its 52-week high.

Setup score 63 out of 100

Latest Close 1.40 AUD 10 Jul 2026

1W Return 0.0% latest completed week

4W Return 3.1% short-term follow-through

12W Return 12.7% quarterly tape

Trend Breadth 82.7% 43 of 52 weeks active

Volume Ratio - vs 13-week average

What is working

The trend backdrop is active with a 19-week active streak.
Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Activity pressure is positive on the latest completed week.

What could go wrong

Next-week expectancy is negative at 43.08% based on similar historical setup states.
2 reversal markers appear in the recent smart-money tape.

What to watch next

Price is close to its 52-week high; watch for continuation or exhaustion.
Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.

Price follow-through 0.0% Latest completed week; four-week move 3.1%. Indicator stack 90/65 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 43.08% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 12 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 20.2% above the Trend Line and sits at 99.6% of its 52-week range. The latest completed week returned 0.0%, after a 3.1% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

0.81 AUD 99.6% 1.40 AUD

Range location99.6%Shows where the latest close sits between the 52-week low and high.

Trend distance20.2%Price premium or discount versus the weekly Trend Line.

Fair-value gap54.6%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-0.2%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is - the 13-week average. Participation data is incomplete.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

16 Jan 23 Jan 30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9012-week average 0.76

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.90Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers22 reversal markers

No recent accumulation markers. 2 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.1% over four weeks, 12.7% over 12 weeks, and 67.0% over one year. The current trend has remained active for 19 consecutive weeks.

Performance by holding period

1W0.0%

4W3.1%

12W12.7%

26W44.8%

52W67.0%

Active trend streak19 weeks

Active weeks in one year43

Trend breadth82.7%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure0.87Latest activity-pressure read.

Pressure change-7.2%Four-week change in activity pressure.

Leadership32.38Latest relative-leadership reading.

RS change-4.1%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks strongly; valuation is inexpensive relative to peers.

Open full factor analysis

Factor week 26 Jul 2026 Financial statements through 30 Jun 2024 Field coverage 85% Model confidence 25%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength97/100Blend of value, momentum, and quality. Underlying universe rank 4; rank 1 is best.

Value87/100Relative valuation strength. Underlying universe rank 14; rank 1 is best.

Quality89/100Profitability and accounting quality. Underlying universe rank 12; rank 1 is best.

Momentum97/100Medium-term price momentum. Underlying universe rank 4; rank 1 is best.

Growth87/100Revenue and earnings growth. Underlying universe rank 14; rank 1 is best.

How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework53/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E: 15.9x
Price / sales: 1.5x
EV / EBITDA: 9.5x
Free-cash-flow yield: 2.0%

Business quality

Margins and the return generated on invested capital.

Gross margin: 62.1%
Operating margin: 12.2%
Free-cash-flow margin: 3.6%
Return on invested capital: 7.9%

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth: 3.1%
EPS growth: 47.7%
Free-cash-flow growth: -
Piotroski F-score: 5/9

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield: 1.4%
Buyback yield: 0.0%
Shareholder yield: 1.4%
Net debt / EBITDA: 1.6x

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 12 relevant articles.

0 positive · 12 neutral · 0 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-0.2%Distance below the 52-week high.

13-week volatility2.4%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

16 Jan 13 Feb 13 Mar 10 Apr 8 May 5 Jun 10 Jul

Weeks higher10 of 2611 weeks finished lower.

Best week+42.9%Week of 6 Mar.

Worst week-4.5%Week of 20 Feb.

Latest week+0.0%Week of 10 Jul.

Shape of recent returns

Strong gains2

Modest gains8

Flat weeks5

Modest losses10

Sharp losses1

Recent vol2.4%13-week weekly-return volatility.

Base vol6.8%52-week weekly-return volatility.

Up/down split24/22Count of positive and negative weeks in the 52-week window.

Average skew4.6% / -2.3%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorAU Healthcare

4-week rank25 / 100

Group average-5.0%

Trend breadth23.0%

Trend23.0%active weekly trend signals

MD60.0%positive activity pressure

RS24.0%positive relative leadership

Four-week leaders

RHT · ASX45.5%AFP · ASX36.2%TTX · ASX27.4%PTX · ASX25.0%EYE · ASX23.8%

IndustryAU Medical Instruments & Supplies

4-week rank3 / 8

Group average-3.1%

Trend breadth12.5%

Trend12.5%active weekly trend signals

MD62.5%positive activity pressure

RS37.5%positive relative leadership

Four-week leaders

OSX · ASX12.5%FPH · ASX3.9%SDI · ASX3.1%ANN · ASX1.0%RMD · ASX-2.3%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape65/100

Trend, activity pressure, participation, and risk combine to a 65/100 tape read.

Indicator analysis86/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 12/12.

Activity pressure 0.90; 2 reversal markers Next-Week ExpectancyNegative 43.08%

Next-week expectancy is negative with a 43.08% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors92/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 61; Small Cap Core rank 23 SVQF53/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 122.5 of 262 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 12 relevant articles.

SDI's (ASX:SDI) $166 Million Takeover: Is Australia Selling Its Dental Technology Champion Too Cheaply? Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
10 Jul 2026	1.40 AUD	0.0%	1.16 AUD	0.90 AUD	0.87	32.38	0	On
3 Jul 2026	1.40 AUD	0.0%	1.15 AUD	0.90 AUD	0.82	33.11	0	On
26 Jun 2026	1.40 AUD	0.4%	1.13 AUD	0.90 AUD	0.94	35.75	1.3M	On
19 Jun 2026	1.39 AUD	2.8%	1.12 AUD	0.89 AUD	0.91	35.67	1.5M	On
12 Jun 2026	1.35 AUD	-0.4%	1.10 AUD	0.89 AUD	0.93	33.76	584.0K	On
5 Jun 2026	1.36 AUD	0.4%	1.09 AUD	0.88 AUD	0.97	38.38	233.3K	On
29 May 2026	1.35 AUD	0.4%	1.08 AUD	0.88 AUD	0.81	37.58	128.0K	On
22 May 2026	1.35 AUD	8.4%	1.06 AUD	0.88 AUD	0.76	39.60	1.8M	On
15 May 2026	1.25 AUD	1.6%	1.05 AUD	0.87 AUD	0.64	30.40	456.6K	On
8 May 2026	1.23 AUD	-0.6%	1.04 AUD	0.87 AUD	0.71	27.65	378.5K	On
1 May 2026	1.23 AUD	0.2%	1.03 AUD	0.86 AUD	0.87	29.56	523.9K	On
24 Apr 2026	1.23 AUD	-0.8%	1.02 AUD	0.86 AUD	0.96	29.42	428.1K	On
17 Apr 2026	1.24 AUD	-0.8%	1.01 AUD	0.86 AUD	1.18	29.05	446.1K	On
10 Apr 2026	1.25 AUD	0.0%	1.00 AUD	0.85 AUD	1.32	30.64	724.2K	On

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.